"Als Deutschlands größte überörtliche kardiologisch-angiologische Gemeinschaftspraxis bieten wir unseren Patienten in Hamburg mit einer Vielzahl an Praxen, Ärzten und medizinischem Fachpersonal ein umfassendes Angebot an diagnostischen, therapeutischen wie auch operativen Leistungen. Dabei sind uns Vertrauen und Zeit für die Patienten besonders wichtig, um die beste Behandlung mit modernsten Verfahren zu finden. Ganz persönlich und ganz in Ihrer Nähe! Vertrauen Sie unserem Erfahrungsschatz. Wir freuen uns darauf, Sie kennenzulernen!"

During the past decade, Cardiologicum Hamburg conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 4 clinical trials were completed, i.e. on average, 23.5% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 1 clinical trials were completed. i.e. 10% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cardiologicum Hamburg" #1 sponsor was "Boston Scientific Corporation" with 4 trials, followed by "Universitätsklinikum Hamburg-Eppendorf" with 3 trials sponsored, "Amgen" with 2 trials sponsored, "Bayer" with 2 trials sponsored and "MicroPort CRM" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cardiologicum Hamburg" #1 collaborator was "Abbott" with 1 trials as a collaborator, "Charite University, Berlin, Germany" with 1 trials as a collaborator, "Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)" with 1 trials as a collaborator, "German Federal Ministry of Education and Research" with 1 trials as a collaborator and "Iqvia Pty Ltd" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Cardiologicum Hamburg" are "Atrial Fibrillation" (3 trials), "Heart Failure" (3 trials), "Cardiovascular Disease" (2 trials), "Hypertension" (2 trials) and "Stroke" (2 trials). Many other conditions were trialed in "Cardiologicum Hamburg" in a lesser frequency.

Most popular intervention types in "Cardiologicum Hamburg" are "Drug" (11 trials), "Device" (9 trials), "Other" (3 trials), "Behavioral" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "bococizumab (PF-04950615)" (2 trials), "Angiographic guided PCI" (1 trials), "Apixaban" (1 trials) and "Apixaban matching placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cardiologicum Hamburg" are 21 trials for "All" genders.

Currently, there are NaN active trials in "Cardiologicum Hamburg". undefined are not yet recruiting, 6 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Cardiologicum Hamburg, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Cardiologicum Hamburg, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 6 trials that are defined as “Not Applicable".